Japan Eyes Public Insurance for iPS Cell-Based Products
Tokyo, April 8 (Jiji Press)–Japan’s Central Social Insurance Medical Council on Wednesday started to discuss extending the public health insurance coverage to two regenerative medicine products using induced pluripotent stem, or iPS, cells. The council, which advises the health minister, is expected